The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
Open accessAbstract
Manipulations capable of breaking host tolerance to induce tissue-specific T cell-mediated inflammation are of central importance to tumor immunotherapy and our understanding of autoimmunity. We demonstrate that androgen ablative therapy induces profuse T cell infiltration of benign glands and tumors in human prostates. T cell infiltration is readily apparent after 7–28 days of therapy and is comprised predominantly of a response by CD4+ T cells and comparatively fewer CD8+ T cells. Also, T cells within the treated prostate exhibit restricted TCR Vβ gene usage, consistent with a local oligoclonal response. Recruitment/activation of antigen-presenting cells in treated prostate tissues may contribute to local T cell activation. The induction of T cell infiltration in prostate tissues treated with androgen ablation may have implications for the immunotherapeutic treatment of prostate cancer as well as other hormone-sensitive malignancies, including breast carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Interactions Between the Gonadal Steroids and the Immune System
Grossman, C. J. (1985) · Science · doi:10.1126/science.3871252 · Cited by 1,051
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Current Protocols in Immunology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142735 · Cited by 785
High-fidelity mRNA amplification for gene profiling
Wang, E., Miller, L. D., Ohnmacht, G. A., Liu, E. T., & Marincola, F. M. (2000) · Nature Biotechnology · doi:10.1038/74546 · Cited by 675
Simons, J. W., Mikhak, B., Chang, J.-F., DeMarzo, A. M., Carducci, M. A., Lim, M. K., Weber, C. E., Baccala, A. A., Goemann, M., Clift, S., et al. (1999) · PubMed · Cited by 463
Hurwitz, A. A., Foster, B. A., Kwon, E. D., Truong, T. N., Choi, E. M., Greenberg, N. M., Burg, M. B., & Allison, J. P. (2000) · PubMed · Cited by 425
Self-citationManipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., & Allison, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8099 · Cited by 394
Self-citationGorski, J., Yassai, M., Zhu, X., Kissela, B., Keever, C., & Flomenberg, N. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1521.a · Cited by 381
Hurwitz, A. A., Yu, T. F.-Y., Leach, D. R., & Allison, J. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10067 · Cited by 378
Costimulatory regulation of T cell function
Chambers, C. A., & Allison, J. P. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80027-1 · Cited by 377
Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374
Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.
Rovere, P. Q., Vallinoto, C., Bondanza, A., Crosti, M., Rescigno, M., Ricciardi‐Castagnoli, P., Rugarli, C., & Manfredi, A. A. (1998) · PubMed · Cited by 352
Gorski, J., Yassai, M., Zhu, X., Kissela, B., Kissella B [corrected to Kissela, B., Keever, C., & Flomenberg, N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5109 · Cited by 342
Cutting Edge: Bystander Apoptosis Triggers Dendritic Cell Maturation and Antigen-Presenting Function
Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C., & Manfredi, A. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4467 · Cited by 309
Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., & Bellone, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.130 · Cited by 293
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., & Thompson, T. C. (2000) · PubMed · Cited by 271
Vesalainen, S., Lipponen, P., Talja, M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0159-2 · Cited by 254
Kwon, E. D., Foster, B. A., Hurwitz, A. A., Madias, C., Allison, J. P., Greenberg, N. M., & Burg, M. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15074 · Cited by 222
Self-citationDemonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy
Sanda, M. G., Ayyagari, S. R., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C., & Simons, J. W. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35032-2 · Cited by 204
Inducing autoimmune disease to treat cancer
Pardoll, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5340 · Cited by 183
Vieweg, J., Rosenthal, F. M., Bannerji, R., et al. (1994) · PubMed · Cited by 181
Tibbetts, T. A., DeMayo, F., Rich, S., Conneely, O. M., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12021 · Cited by 171
CYTOKINE VARIATIONS IN PATIENTS WITH HORMONE TREATED PROSTATE CANCER
Wise, G. J., Marella, V. K., Talluri, G. S., & Shirazian, D. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67289-8 · Cited by 152
PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER
Troy, A., DAVIDSON, P., Atkinson, C. H., & Hart, D. N. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63093-3 · Cited by 151
Principles and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 147
MOKYR, M. B., Kalinichenko, T. V., Gorelik, L., & Bluestone, J. A. (1998) · PubMed · Cited by 147
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor.
Small, E. J., Reese, D., Um, B., Whisenant, S. P., Dixon, S. C., & Figg, W. D. (1999) · PubMed · Cited by 145
Armas, O. A., Aprikian, A. G., Melamed, J., Cordon‐Cardo, C., Cohen, D. W., Erlandson, R. A., Fair, W. R., & Reuter, V. E. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199410000-00002 · Cited by 140
Fong, L. H., Ruegg, C. L., Brockstedt, D. G., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3113 · Cited by 128
Sex‐hormone‐induced inflammation and fibromuscular proliferation in the rat lateral prostate
Robinette, C. L. (1988) · The Prostate · doi:10.1002/pros.2990120310 · Cited by 125
Isaacs, J. T., Furuya, Y., & Berges, R. S. (1994) · PubMed · Cited by 107
Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice
Ellis, T. M., Moser, M. T., Le, P. T., Flanigan, R. C., & Kwon, E. D. (2001) · International Immunology · doi:10.1093/intimm/13.4.553 · Cited by 98
Self-citationExpression of proinflammatory genes during estrogen-induced inflammation of the rat prostate
Harris, M. T., Feldberg, R. S., Lau, K., Lazarus, N. H., & Cochrane, D. E. (2000) · The Prostate · doi:10.1002/1097-0045(20000615)44:1<19::aid-pros3>3.0.co;2-s · Cited by 95
Costimulatory wars: the tumor menace
Hurwitz, A. A., Kwon, E. D., & van Elsas, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00147-3 · Cited by 74
Self-citationPathological changes in prostate lesions after androgen manipulation.
Montironi, R., & Schulman, C. C. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.1.5 · Cited by 58
Cited by
Kwon, E. D., Drake, C. G., Scher, H. I., Fizazi, K., Bossi, A., van den Eertwegh, A. J. M., Krainer, M., Houede, N., Santos, R., Mahammedi, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70189-5 · Cited by 1,511
Self-citationCTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Prostate cancer and inflammation: the evidence
Sfanos, K. S., & De Marzo, A. M. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04033.x · Cited by 612
Metadata
- Authors
- Mercader, M., Bodner, B. K., Moser, M. T., Kwon, P. S., Park, E. S. Y., Manecke, R. G., Ellis, T. M., Wojcik, E. M., Yang, D., Flanigan, R. C., Waters, W. B., Kast, W. M., & Kwon, E. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-12-04
- Volume
- 98
- Issue
- 25
- Pages
- 14565-14570
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2143445035
- Cited by
- 393
- References
- 42
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.